Cargando…
SonoVue(®) vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?
The use of ultrasound and microbubbles to enhance therapeutic efficacy (sonoporation) has shown great promise in cancer therapy from in vitro to ongoing clinical studies. The fastest bench-to-bedside translation involves the use of ultrasound contrast agents (microbubbles) and clinical diagnostic sc...
Autores principales: | Kotopoulis, Spiros, Popa, Mihaela, Mayoral Safont, Mireia, Murvold, Elisa, Haugse, Ragnhild, Langer, Anika, Dimcevski, Georg, Lam, Christina, Bjånes, Tormod, Gilja, Odd Helge, Cormack, Emmet Mc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777813/ https://www.ncbi.nlm.nih.gov/pubmed/35056994 http://dx.doi.org/10.3390/pharmaceutics14010098 |
Ejemplares similares
-
Head-to-head comparison of Sonazoid and SonoVue in the diagnosis of hepatocellular carcinoma for patients at high risk
por: Huang, Jiayan, et al.
Publicado: (2023) -
Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cells
por: Haugse, Ragnhild, et al.
Publicado: (2020) -
Contrast-enhanced ultrasonography of the liver using SonoVue
por: Ferraioli, Giovanna, et al.
Publicado: (2018) -
Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021) -
Optimal Control of SonoVue Microbubbles to Estimate Hydrostatic Pressure
Publicado: (2019)